| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 |
| Total Revenue | 0 | 0 | 1 | 1,013 |
| Cost of Revenue |
-
|
-
|
-
|
-
|
|
| Gross Profit | 0 | 0 | 1 | 1,013 |
|
| Operating Expenses |
| Research Development |
-
|
-
|
-
|
-
|
| Selling General and Administrative | 235 | 211 | 332 | 273 |
| Non Recurring | (776) |
-
|
-
|
-
|
| Others | 542 | (211) | (331) |
-
|
| |
| Total Operating Expenses |
-
|
-
|
-
|
-
|
|
|
| Operating Income or Loss |
-
|
-
|
-
| 740 |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
| Earnings Before Interest And Taxes |
-
|
-
|
-
| 740 |
| Interest Expense |
-
|
-
|
-
|
-
|
| Income Before Tax |
-
|
-
|
-
| 740 |
| Income Tax Expense |
-
|
-
|
-
|
-
|
| Minority Interest |
-
|
-
|
-
|
-
|
| |
| Net Income From Continuing Ops |
-
|
-
|
-
| 740 |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
| Net Income |
-
|
-
|
-
| 740 |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares |
-
|
-
|
-
| $740 |
0.08% Nasdaq 
0.60%
Income Statement
